- Mylan's generic Precose gets green light from FDA
- New alliance will crack down on adulterated products touting dietary supplement claims
- Perrigo gains entry to store-brand blood-glucose meter market
- Adherence among chronic disease patients can lead to big savings
- Nipro showcases diabetes-friendly energy shot
NEW YORK — Philosys is seeking regulatory approval from the Food and Drug Administration for its blood-glucose monitoring system.
Gmate Smart, which the company calls "the smallest and most innovative meter in the world," is a blood-glucose meter that works with the headphone connector of the iPhone, iPad and iPod.
"We are very excited to be close to FDA approval for our blood glucose monitoring technology and are preparing to bring this capability to the United States," Philosys operations manager Jennifer Kupar said. Gmate Smart is the world's first 'true smartphone meter.' Given the dramatic rise of diabetes in the U.S. and more tech savvy consumers, there is a growing demand for this medical technology that Philosys can meet. Gmate is the perfect solution for diabetics seeking digital solutions to monitor their disease with the push of a button. We look forward to FDA approval of our revolutionary device this year."
Philosys said it expects to receive approval for the meter in third quarter 2012.